References
1. Sridharan SE, Unnikrishnan JP, Sukumaran S, Sylaja PN, Nayak SD, Sarma PS, et al. Incidence, types, risk factors and outcome of stroke in a developing country. Stroke 2009; 40(4): 1212-18
2. World Heart Federation (CH). World Heart Federation: Stroke (Internet). Geneva : World Heart Federation; 2016 (cited 2016 Sep 20) Available from: www.world-heart federation.org/ cardiovascular-health/stroke/
3. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Bass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association / Ameri-can Stroke Association stroke council. Stroke 2006; 37: 1583-1633
4. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guide-line for healthcare professionals from the American Heart Association / American Stroke Association. Stroke 2011; 42(1): 227-76
5. Maegdefessel L, Azuma J, Tsao PS. Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. Vasc Health Risk Manag 2010; 6: 95-103
6. Kernan W N, Ovbiagele B, Black HR, Bravata DM, Chimowitz M, Ezekowitz M D. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guide-line for healthcare professionals from the American Heart Association / American Stroke Association. Stroke 2014;45: 2160-2236
7. National Institute of Neurological Disorders and Stroke (US). Stroke: Hope Through Research (Internet). Bethesda: National Institute of Health; 2015 (last updated 2016 May 26; cited 2016 Jul 22). Available from www.ninds.nih.gov ›Disorders A - Z › Stroke
8. Hinojar R, Jime´nez-Natcher JJ, Ferna´ndez-Golfý´n C, Zamorano JL. New oral anticoagulants: A practical guide for physicians. European Heart Journal – Cardiovascular Pharmacotherapy 2015; 1: 134-45
9. Rich MW. Epidemiology of atrial fibrillation. J Interv Card Electrophysiol 2009; 25: 3-8
10. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K an-tagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3): 204-33
11. Yahaya, Hassali, Awaisu, Shafie. Factors associated with warfarin therapy knowledge and anticoagulation control among patients attending a Warfarin Clinic in Malaysia. Journal of clinical and Diagnostic Research 2009; 3(4): 1663-70
12. Madrid AH, Potpara TS, Dagres N, Chen J, Larsen TB, Estner H, et al. Differences in attitude, education, and knowledge about oral anticoagulation therapy among pa-tients with atrial fibrillation in Europe: Result of a self-assessment patient survey conducted by the European Heart Rhythm association. Europace 2016; 18(3): 463-67
13. Al-Omair SF, Musallam NA, Al-deghaither NY, Al-Sadoun NA, Bayoumy NM. Compliance with and awareness about long-term oral anticoagulant therapy among Saudi pa-tients in a University Hospital, Riyadh, Saudi Arabia. J Appl Hematol 2016; 7: 10-16
14. Alphonsa A, Sharma KK, Sharma G, Bhatia R. Knowledge regarding oral anticoagulation among patients with stroke and those at high risk of thromboembolic events. Journal of Stroke and Cerebrovascular Diseases 2015; 24(3): 668-72
15. Joshua JK, Kakkar N. Lacunae in patient knowledge about oral anticoagulant treatment: results of a questionnaire survey. Indian J Hematol Blood Transfus 2015; 31(2): 275-80
16. Khudair IF, Hanssens YI. Evaluation of patients’ knowl-edge on Warfarin in outpatient anticoagulation clinics in a teaching hospital in Qatar. Saudi Med J 2010; 31: 672-77.
Author:Jinu Joseph1, Saramma PP2, Sylaja PN3
The authors are: 1. II Year Diploma in Neuronursing student; 2. Senior Lecturer in Nursing and ; 3. Additional Professor of Nursing & I/c Compre-hensive Stroke Care Programme, all at Sree Chitra Tirunal Institute for Medical Sciences & Technology, Thiruvananthapuram (Kerala).
Source: TNAI Journal
Click for more Nursing Articles